Stock Analysts’ upgrades for Tuesday, October 22nd:
Aegon (NYSE:AEG) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating.
Can-Fite BioPharma (NYSE:CANF) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Fluor (NYSE:FLR) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating. Citigroup Inc. currently has $65.00 target price on the stock, up from their previous target price of $52.00.
First Solar (NASDAQ:FSLR) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating. Citigroup Inc. currently has $254.00 target price on the stock, up from their previous target price of $200.00.
IAMGOLD (NYSE:IAG) (TSE:IMG) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating.
IAMGOLD (NYSE:IAG) (TSE:IMG) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating.
Samsara (NYSE:IOT) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
3M (NYSE:MMM) was upgraded by analysts at Melius from a hold rating to a buy rating.
3M (NYSE:MMM) was upgraded by analysts at Melius Research from a hold rating to a buy rating. The firm currently has $180.00 target price on the stock.
Oramed Pharmaceuticals (NASDAQ:ORMP) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Paylocity (NASDAQ:PCTY) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. They currently have $200.00 target price on the stock, up from their previous target price of $145.00.
Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.
United States Lime & Minerals (NASDAQ:USLM) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Washington Trust Bancorp (NASDAQ:WASH) was upgraded by analysts at Piper Sandler from an underweight rating to a neutral rating. Piper Sandler currently has $34.00 target price on the stock, up from their previous target price of $30.00.
Wyndham Hotels & Resorts (NYSE:WH) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Receive News & Ratings for Aegon Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aegon Ltd and related companies with MarketBeat.com's FREE daily email newsletter.
